Project Details
SFB 1324: Mechanisms and functions of Wnt signaling
Subject Area
Biology
Term
since 2017
Website
Homepage
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 331351713
Over the past two decades, Heidelberg and the Rhine-Neckar area have become a world-leading hub for Wnt signaling research, with CRC 1324 at its center. CRC 1324 aims to mechanistically and quantitatively understand how Wnt signals are produced, sensed, and translated into context-dependent responses during development and disease. Using model organisms and human disease systems, we explore conserved and diversified features of Wnt signaling across scales, linking pathway regulation to function in health and pathology.Wnt ligands are lipidated, secreted proteins that bind various receptors to activate conserved cytoplasmic cascades. Wnt pathways govern embryonic patterning, stem cell maintenance, tissue homeostasis, and aging, and are implicated in many human diseases. Despite the identification of key components, fundamental questions remain about spatial and temporal regulation, signaling specificity, and context-dependent downstream responses. Wnt signaling is thus both a paradigmatic signal transduction model and a target for therapeutic intervention.CRC 1324’s strategy involves cross-species analysis of Wnt secretion, receptor engagement, and downstream coupling. Using Hydra, Drosophila, Xenopus, zebrafish, mouse, and human systems, we apply multiscale imaging, proteomics, structural biology, single-cell omics, and modeling to reveal conserved mechanisms and accelerate translational insight.In the first funding period, CRC 1324 integrated quantitative approaches into developmental and human models, e.g., measuring ligand-receptor affinities in live cells via axial line-scanning fluorescence correlation spectroscopy. In the second period, we expanded to include Heidelberg groups focused on Wnt-driven diseases, intensified interdisciplinary collaboration, and addressed the regulation of Wnt signaling in space and time at organismal levels. In the third funding period, we will link mechanistic insights, on ligand biogenesis, signal regulation, metabolic integration, mechanobiology, and stem cell plasticity, to disease-relevant models. This mechanism-to-model continuum ensures that molecular and structural insights are tested in relevant biological contexts. Building on established collaborations, we refine projects and formulate new questions connecting pathway analysis to in vivo function in oncology, cardiology, and nephrology.CRC 1324 is structured into two mechanism-based research areas: (A) Wnt secretion and receptor-ligand interactions: We study how Wnt proteins are modified, secreted, and trafficked, focusing on cell-type specific secretion and receptor codes. (B) Wnt coupling to downstream and context-specific signaling: We examine how distinct pathways elicit specific outcomes, using imaging and single-cell approaches to define dynamic regulation and metabolic influences.CRC 1324 combines mechanistic depth with translational reach to define how dynamic Wnt architectures govern development, tissue function, and disease.
DFG Programme
Collaborative Research Centres
Current projects
- A01 - Mechanisms of Wnt protein secretion (Project Heads Boutros, Michael ; Sinning, Irmgard )
- A02 - Mechanisms of vascular Wnt signaling during liver homeostasis and tumorigenesis (Project Head Augustin, Hellmut G. )
- A05 - The Wnt code: Deciphering early Wnt interactions in Hydra (Project Heads Holstein, Thomas W. ; Tanaka, Motomu )
- A07 - Cell-specific activation of Wnt signaling in healing after myocardial infarction (Project Head Leuschner, Florian )
- A08 - Wnt pathway specificity in niche – stem cell control (Project Heads Bageritz, Josephine ; Lohmann, Ingrid )
- B01 - Role of DDX56 in GSK3β regulation during Wnt signaling (Project Head Niehrs, Ph.D., Christof )
- B02 - Mechanism of oscillatory Wnt signaling dynamics and its role in vertebrate embryos (Project Heads Aulehla, Alexander ; Simons, Matias )
- B03 - The roles of Wnt signaling in genome stability (Project Heads Acebrón, Sergio Pérez ; Bastians, Holger )
- B05 - Mathematical modeling of spatio-temporal dynamics of Wnt signaling and its function in development and regeneration (Project Head Marciniak-Czochra, Anna )
- B06 - Orchestration of stem- and EMT-like phenotypes by Wnt signaling (Project Head Martin-Villalba, Ana )
- B07 - Uncovering novel molecular mechanisms within Wnt signaling (Project Heads Sinning, Irmgard ; Özbek, Suat )
- B08 - Mechanism of AXIN1 degradation after MEK inhibition (Project Head Zhan, Tianzuo )
- B10 - Decoding the role and regulation of Wnt/STOP in drug-resistant cancer cells for personalized treatment strategies (Project Head Hinze, Laura )
- B11 - The role of Wnt signaling in controlling neuromesodermal progenitor cell plasticity in teleost species (Project Heads Aulehla, Alexander ; Saunders, Lauren )
- Z01 - Central administration (Project Head Boutros, Michael )
- Z02 - Advanced fluorescence microscopy (Project Heads Davidson, Gary ; Engel, Ulrike )
- Z03 - Advanced genetic screens and genome-engineering (Project Head Boutros, Michael )
- Z04 - Advanced proteomics (Project Head Krijgsveld, Jeroen )
Completed projects
- A03 - Ykt6-dependent trafficking of Wnts (Project Head Gross, Julia )
- A04 - Roles of lipids in Wnt secretion and signaling (Project Heads Boutros, Michael ; Brügger, Britta )
- A06 - Quantitative fluorescence microscopy for the analysis of Wnt pathway interactions and dynamics (Project Heads Davidson, Gary ; Nienhaus, Gerd Ulrich )
- B04 - Wnt signaling in fate determination of retinal precursors (Project Head Wittbrodt, Joachim )
- B09 - Wnt-cilia signaling in epithelial polarization and renal development (Project Heads Pereira, Gislene ; Simons, Matias )
Applicant Institution
Ruprecht-Karls-Universität Heidelberg
Participating University
Georg-August-Universität Göttingen; Heinrich-Heine-Universität Düsseldorf; Karlsruher Institut für Technologie
Participating Institution
Deutsches Krebsforschungszentrum (DKFZ); European Molecular Biology Laboratory (EMBL)
Spokespersons
Professor Dr. Michael Boutros, since 7/2021; Professor Dr. Thomas W. Holstein, until 6/2021
